Skip to content
10-Q/A

Quarterly Report

GT Biopharma, Inc. GTBP

0001493152-26-009127

← back to feed
Filed
Mar 6, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 3.56M sh
Shares Diluted Q2 2025 · Jun 30, 2025 2.77M sh
Shares Diluted Q2 2025 · Jun 30, 2025 2.56M sh
Shares Diluted Q2 2025 · Jun 30, 2024 1.71M sh
Shares Diluted Q2 2025 · Jun 30, 2024 1.55M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$5.22M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$7.7M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $5.23M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $3.95M
Stockholders Equity restated Q2 2025 · Jun 30, 2025 −$25.88M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$980K
Stockholders Equity Q2 2025 · Dec 31, 2024 −$1.67M
Stockholders Equity Q2 2025 · Jun 30, 2024 $5.51M
Stockholders Equity Q2 2025 · Mar 31, 2024 $5.31M
Stockholders Equity Q2 2025 · Dec 31, 2023 $7.48M
Current Liabilities restated Q2 2025 · Jun 30, 2025 $31.04M
Current Liabilities Q2 2025 · Dec 31, 2024 $5.9M
Total Liabilities Q2 2025 · Jun 30, 2025 $31.04M
Current Assets Q2 2025 · Jun 30, 2025 $7.12M
Current Assets Q2 2025 · Dec 31, 2024 $4.23M
Total Assets Q2 2025 · Jun 30, 2025 $7.12M
Eps Diluted restated Q2 2025 · Jun 30, 2025 −$10.92
Eps Diluted restated Q2 2025 · Jun 30, 2025 −$12.12
Eps Diluted Q2 2025 · Jun 30, 2024 −$2.17
Eps Diluted Q2 2025 · Jun 30, 2024 −$3.86
Eps Basic restated Q2 2025 · Jun 30, 2025 −$10.92
Eps Basic restated Q2 2025 · Jun 30, 2025 −$12.12
Eps Basic Q2 2025 · Jun 30, 2024 −$2.17
Eps Basic Q2 2025 · Jun 30, 2024 −$3.86
Sga Expense Q2 2025 · Jun 30, 2025 $1.15M
Sga Expense Q2 2025 · Jun 30, 2025 $1.98M
Sga Expense Q2 2025 · Jun 30, 2024 $2.12M
Sga Expense Q2 2025 · Jun 30, 2024 $4.44M
Rd Expense Q2 2025 · Jun 30, 2025 $363K
Rd Expense Q2 2025 · Jun 30, 2025 $1.46M
Rd Expense Q2 2025 · Jun 30, 2024 $1.78M
Rd Expense Q2 2025 · Jun 30, 2024 $2.56M
Net Income restated Q2 2025 · Jun 30, 2025 −$30.17M
Net Income restated Q2 2025 · Jun 30, 2025 −$30.95M
Net Income Q2 2025 · Jun 30, 2024 −$3.71M
Net Income Q2 2025 · Jun 30, 2024 −$5.98M
Operating Income Q2 2025 · Jun 30, 2025 −$1.51M
Operating Income Q2 2025 · Jun 30, 2025 −$3.45M
Operating Income Q2 2025 · Jun 30, 2024 −$3.91M
Operating Income Q2 2025 · Jun 30, 2024 −$7M